-
#HepaRegeniX GmbH schließt Finanzierungsrunde über €11 Mio. ab mit#BoehringerIngelheim (BIVF),#NovoHoldings,#Coparion,@HTGF und#Ascenion Starke Leistung in Tübingen! Gratulation zur Series B!@uktuebingen@IHK_Reutlingen@startuptue@startup_tue -
Congrats
Our #portfolio company#HepaRegeniX secures Series B Financing in excess of €11 Mio. to advance first drug candidate to the clinic. The company is developing a novel therapy for the treatment of acute and chronic liver diseases.#HTGFFamily
http://high-tech-gruenderfonds.de/en/heparegenix-gmbh-secures-series-b-financing-in-excess-of-e11-mio-to-advance-first-drug-candidate-to-the-clinic/ …pic.twitter.com/z2SryQsr1e
-
HepaRegeniX GmbH Secures Series B Financing in Excess of €11 Mio. to Advance First Drug Candidate to the Clinic https://www.b3cnewswire.com/202001212030/heparegenix-gmbh-secures-series-b-financing-in-excess-of-11-mio-to-advance-first-drug-candidate-to-the-clinic.html …
#Heparegenix More German life science business news at [LSG] at https://www.life-sciences-germany.com/news/Life-Sciences-Twitter-Germany-Deutschland-Allemagne-News-List-Table-Press-Release-1001-104-10-0-2-desc.html …pic.twitter.com/nfbFN6ifSP
-
HepaRegeniX GmbH Appoints Michael Lutz as New CEO/Managing Director https://www.heparegenix.com/pdf/2019-10-17_PR_management%20changes.pdf …
#Heparegenix More German life science business news at [LSG] at https://www.life-sciences-germany.com/news/Life-Sciences-Twitter-Germany-Deutschland-Allemagne-News-List-Table-Press-Release-1001-104-10-0-2-desc.html …pic.twitter.com/SMwzEiyv26
-
#HepaRegeniX GmbH Announces Management Changes, Dr. Michael Lutz appointed as new CEO/Managing Director https://www.b3cnewswire.com/201910171987/heparegenix-gmbh-announces-management-changes.html …#biotechpic.twitter.com/GZAQTKNCff
-
#HepaRegeniX Raises €9M in Series A Financing. Read more: http://owler.us/ab9ra8 -
#HepaRegeniX GmbH Raises €9 Million In A Series A Financing To Develop Kinase Inhibitors Fo... Read more: http://owler.us/ab9lFC -
.
#HepaRegeniX raises €9M to develop regenerative#liver therapeutics:http://ow.ly/m2A1307Ic4F -
€9M raised by
#HepaRegeniX toward developing regenerative#liver treatments: http://ow.ly/m2A1307Ic4F -
NEW
#EUROPE#BIOTECH#STARTUP:#HepaRegeniX LANDS €9m for the Treatment of Acute and Chronic#Liver Diseases http://high-tech-gruenderfonds.de/en/heparegenix-gmbh-raises-e9-million-in-a-series-a-financing-to-develop-kinase-inhibitors-for-the-treatment-of-acute-and-chronic-liver-diseases/ …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.